VistaGen Therapeutics Announces Appointment of Mary L. Rotunno to its Board of Directors

Author's Avatar
Jul 07, 2021

Ms. Rotunno brings extensive healthcare industry expertise as a leader and strategist as VistaGen advances late-stage development of its product candidates for anxiety and depression disorders